TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / 3T Biosciences Stock

3T Biosciences Stock

www.3tbiosciences.comHealthcare / BioTech & PharmaFounded: 2017

3T Biosciences is a medical research and drug development company. Targeting T-cell-mediated diseases such as cancer, 3T Biosciences has a mission to create new treatments for patients by incorporating machine learning and synthetic biology. The company uses its T-cell science methodology to address concerns with immunotherapy with treatment that is less invasive. 3T Biosciences was founded by Leah Sibener, Luke Lee, and Marvin Gee in 2017 and is headquartered in San Francisco, CA.

Buy or sell 3T Biosciences stockLearn more about 3T Biosciences IPO

Register To Buy and Sell Shares

For more details on financing and valuation for 3T Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access 3T Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like 3T Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

3T Biosciences investors also invested in these private companies

Lightspeed Venture Partners
Menlo Ventures
CRV
Starlight Ventures
Westlake Village BioPartners
Johnson & Johnson Innovation
Thiel Capital
Asset Management Ventures
Hayan Health Networks
Parker Institute for Cancer Immunotherapy
OS Fund

Team

Management Team

Stefan Scherer Ph.D
Chief Executive Officer
Estelle Marrer-Berger
Chief Development Officer
Bryan Irving Ph.D
Chief Scientific Officer
Leah Sibener
Co-Founder & Vice President of Therapeutic Discovery
Marvin Gee
Co-Founder & Vice President of Target Discovery
Susan Wong
Vice President & Head of Finance
Christopher DeRespino
Chief Business Officer

Board Members

Beth Seidenberg MD
Westlake Village BioPartners
Louis Lange MD
Asset Management Ventures
Sean Harper MD
Westlake Village BioPartners
Sean Parker
Parker Institute for Cancer Immunotherapy

Frequently Asked Questions About 3T Biosciences’ Stock

plusminus
Can you buy 3T Biosciences’ stock?
3T Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy 3T Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell 3T Biosciences’ stock?
Yes, you can sell stock of a private company like 3T Biosciences. Forge can help you sell your 3T Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is 3T Biosciences’ stock price?
3T Biosciences is a privately held company and therefore does not have a public stock price. However, you may access 3T Biosciences’ private market stock price with Forge Data.
plusminus
What is 3T Biosciences’ stock ticker symbol?
3T Biosciences does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like 3T Biosciences in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

Pharmaceutical Technology 01/05/2024
Boehringer and 3T Biosciences partner to develop cancer immunotherapies
In a preliminary research deal, 3T biosciences is beginning to identify antigen treatments for cancer immunotherapy.

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.